BORIS-siRNA

N/A

Report date: 2024/11/07 17:54:18
NME

Base Information

Drug NameBORIS-siRNA
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTranscriptional repressor CTCFL inhibitors
TargetsTranscriptional repressor CTCFL
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFlorida Atlantic University
China Registration ClassN/A

Develop Information

Active CompaniesFlorida Atlantic University
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A